Overview

Postpartum Heparin Against Venous Thromboembolism: a Pilot Randomized Controlled Trial

Status:
Completed
Trial end date:
2023-03-13
Target enrollment:
Participant gender:
Summary
In previous attemps to answer the question of risk-benefit of postpartum thromboprophylaxis, researchers were faced with low recruitement rates. The goal of this pilot feasibility randomized controlled trial of postpartum pharmacological thromboprophylaxis is to examine the feasibility (recruitement rate) and participation rate at the Geneva University Hospitals
Phase:
Phase 3
Details
Lead Sponsor:
University Hospital, Geneva
Treatments:
Enoxaparin